Laccure AB has developed a product for women with bacterial vaginosis. Due to its extended release of lactic acid, one vaginal tablet is the entire treatment! Its safety and efficacy has been confirmed in clinical trials, performed according to ICH GCP. The product is classified as a medical device IIb. Laccure AB is one of several project companies of Aqilion AB (former PULS AB). For further information see www.laccure.com